A pooled multisite analysis of the effects of atopic medical conditions in glioma risk in different ethnic groups

Annals of Epidemiology

Volumn 25, Issue 4, 2015, Pages 270-274

  Krishnamachari, Bhuma ^a   Il'yasova, Dora ^c   Scheurer, Michael E ^d   Bondy, Melissa ^d   Zhou, Renke ^d   Wrensch, Margaret ^e   Davis, Faith ^b  

^a NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c DUKE CANCER INSTITUTE   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Allergies; Atopic conditions; Glioma

Indexed keywords

ADULT; ALLERGIC ASTHMA; ARTICLE; ASIAN; ATOPIC DERMATITIS; ATOPY; BLACK PERSON; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; GLIOBLASTOMA; GLIOMA; HISPANIC; HISTOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SELF REPORT; SEX DIFFERENCE; SEX RATIO; ANCESTRY GROUP; CASE CONTROL STUDY; CLINICAL TRIAL; COMPLICATION; ETHNIC GROUP; HYPERSENSITIVITY; MIDDLE AGED; MULTICENTER STUDY; STATISTICS AND NUMERICAL DATA;

CASE-CONTROL STUDIES; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; GLIOBLASTOMA; GLIOMA; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED;

EID: 84925241495     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2014.12.007     Document Type: Article

References (32)

1. Ostrom Q.T., Gittleman H., Farah P., Ondracek A., Chen Y., Wolinsky Y., et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States 2006-2010. Neuro-Oncol 2013, 15(suppl. 2):ii1-ii56.
2. Preston D.L., Ron E., Yonehara S., Kobuke T., Fujii H., Kishikawa M., et al. Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. JNatl Cancer Inst 2002, 94(20):1555-1563.
3. Yonehara S., Brenner A.V., Kishikawa M., Inskip P.D., Preston D.L., Ron E., et al. Clinical and epidemiologic characteristics of first primary tumors of the central nervous system and related organs among atomic bomb survivors in Hiroshima and Nagasaki, 1958-1995. Cancer 2004, 101(7):1644-1654.
4. Wiemels J.L., Wiencke J.K., Sison J.D., Miike R., McMillan A., Wrensch M. History of allergies among adults with glioma and controls. Int J Cancer 2002, 98(4):609-615.
5. Wigertz A., Lönn S., Schwartzbaum J., Hall P., Auvinen A., Christensen H.C., et al. Allergic conditions and brain tumor risk. Am J Epidemiol 2007, 166(8):941-950.
6. Schlehofer B., Blettner M., Preston-Martin S., Niehoff D., Wahrendorf J., Arslan A., et al. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 1999, 82(2):155-160.
7. Linos E., Raine T., Alonso A., Michaud D. Atopy and risk of brain tumors: a meta-analysis. JNatl Cancer Inst 2007, 99(20):1544-1550.
8. Il'yasova D., McCarthy B., Marcello J., Schildkraut J.M., Moorman P.G., Krishnamachari B., et al. Association between glioma and history of allergies, asthma, and eczema: a case-control study with three groups of controls. Cancer Epidemiol Biomarkers Prev 2009, 18(4):1232-1238.
9. Chen C., Xu T., Chen J., Zhou J., Yan Y., Lu Y., et al. Allergy and risk of glioma: a meta-analysis. Eur J Neurol 2011, 18(3):387-395.
10. Amirian E., Marquez-Do D., Bondy M., Scheurer M.E. Antihistamine use and immunoglobulin E levels in glioma risk and prognosis. Cancer Epidemiol 2013, 37(6):908-912.
11. McCarthy B., Rankin K., Aldape, Bondy M., Brännström T., Broholm H., et al. Risk factors for oligodendroglial tumors: a pooled international study. Neuro Oncol 2011, 13(2):242-250.
12. Turner M., Krewski D., Armstrong B., Chetrit A., Giles G., Hours M., et al. Allergy and brain tumors in the INTERPHONE study: pooled results from Australia, Canada, France, Israel, and New Zealand. Cancer Causes Control 2013, 24(5):949-960.
13. Dubrow R., Darefsky A. Demographic variation in incidence of adult glioma by subtype, United States, 1992-2007. BMC Cancer 2011, 11:325.
14. Chen P., Aldape K., Wiencke J.K., Kelsey K.T., Miike R., Davis R.L., et al. Ethnicity delineates different genetic pathways in malignant glioma. Cancer Res 2001, 61(10):3949-3954.
15. Jacobs D., Walsh K.M., Wrensch M., Wiencke J., Jenkins R., Houlston R.S., et al. Leveraging ethnic group incidence variation to investigate genetic susceptibility to glioma: a novel candidate SNP approach. Front Genet 2012, 3:203.
16. Sun J.Y., Zhang C.Y., Zhang Z.J., Dong Y.F., Zhang A.L., Wang Z.W., et al. Association between XRCC1 gene polymorphisms and risk of glioma development: a meta-analysis. Asian Pac J Cancer Prev 2012, 13(9):4783-4788.
17. Wegienka G., Johnson C., Zoratti E., Havstad S. Racial differences in allergic sensitization: recent findings and future directions. Curr Allergy Asthma Rep 2013, 13(3):255-261.
18. Piacentini S., Polimanti R., Simonelli I., Donno S., Pasqualetti P., Manfellotto D., et al. Glutathione S-transferase polymorphisms, asthma susceptibility and confounding variables: a meta-analysis. Mol Biol Rep 2013, 40(4):3299-3313.
19. Schwartzbaum J., Ahlbom A., Malmer B., Lönn S., Brookes A.J., Doss H., et al. Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res 2005, 65(14):6459-6465.
20. Wiemels J.L., Wiencke J.K., Kelsey K.T., Moghadassi M., Rice T., Urayama K.Y., et al. Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev 2007, 16(6):1229-1235.
21. Silverberg J.I., Hanifin J.M. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. JAllergy Clin Immunol 2013, 132(5):1132-1138.
22. Yang J.J., Burchard E.G., Choudhry S., Johnson C.C., Ownby D.R., Favro D., et al. Differences in allergic sensitization by self-reported race and genetic ancestry. JAllergy Clin Immunol 2008, 122(4):820-827.
23. Cahoon E., Inskip P., Gridley G., Brenner A. Immune-related conditions and subsequent risk of brain cancer in a cohort of 4.5 million male US veterans. Br J Cancer 2014, 110(7):1825-1833.
24. Amirian E., Scheurer M.E., Bondy M.L. The association between birth order, sibship size and glioma development in adulthood. Int J Cancer 2010, 126(11):2752-2756.
25. Wrensch M., McMillan A., Wiencke J., Wiemels J., Kelsey K., Patoka J., et al. Nonsynonymous coding single-nucleotide polymorphisms spanning the genome in relation to glioblastoma survival and age at diagnosis. Clin Cancer Res 2007, 13(1):197-205.
26. Hochberg F., Toniolo P., Cole P., Salcman M. Nonoccupational risk indicators of glioblastoma in adults. JNeurooncol 1990, 8(1):55-60.
27. Brenner A.V., Linet M.S., Fine H.A., Shapiro W.R., Selker R.G., Black P.M., et al. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 2002, 99(2):252-259.
28. Schoemaker M.J., Swerdlow A.J., Hepworth S.J., McKinney P.A., van Tongeren M., Muir K.R. History of allergies and risk of glioma in adults. Int J Cancer 2006, 119(9):2165-2172.
29. Ryan P., Lee M.W., North B., McMichael A.J. Risk factors for tumors of the brain and meninges: results from the Adelaide Adult Brain Tumor Study. Int J Cancer 1992, 51(1):20-27.
30. Cicuttini F.M., Hurley S.F., Forbes A., Donnan G.A., Salzberg M., Giles G.G., et al. Association of adult glioma with medical conditions, family and reproductive history. Int J Cancer 1997, 71(2):203-207.
31. Jenkins R.B., Wrensch M.R., Johnson D., Fridley B.L., Decker P.A., Xiao Y., et al. Distinct germline polymorphisms underlie glioma morphologic heterogeneity. Cancer Genet 2011, 204(1):13-18.
32. Bondy M.L., Scheurer M.E., Malmer B., Barnholtz-Sloan J.S., Davis F.G., et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 2008, 113(Suppl. 7):1953-1968.